Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several factors contribute to this increased frequency, including consanguineous marriages and an event known as a “bottleneck”, which occurred in the past and caused a drastic reduction in the genetic variability of this population. Several studies were performed over the years in an attempt to elucidate the role of BRCA1 and BRCA2 genes in susceptibility to breast cancer. The aim of this study was to estimate the carrier frequency of certain common mutations in theBRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) genes in an Ashkenazi Jewish population from Porto Alegre, Brazil. Molecular analyses were done by PCR followed by RFLP (ACRS). The carr...
carry one of three founding mutations in the BRCA1 and BRCA2 genes, and each mutation is associated ...
Of all malignant neoplasias affecting women, breast cancer has the highest incidence rate in Brazil....
International audienceThree founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditar...
Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several ...
SummaryBased on breast cancer families with multiple and/or early-onset cases, estimates of the life...
O câncer de mama é um dos mais incidentes no mundo e mais comum na população feminina. Algumas popul...
About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline m...
About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline m...
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and ...
Abstract About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from g...
In Ashkenazi Jewish (AJ) high risk families 3 mutations [2 in BRCA1 (c. 68_69del and c.5266dup) and ...
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma s...
The discovery of BRCA1 and BRCA2 genes has led to the introduction of increasingly sophisticated gen...
Ovarian cancer is a component of the autosomal-dominant hereditary breast-ovarian cancer syndrome an...
Abstract Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ...
carry one of three founding mutations in the BRCA1 and BRCA2 genes, and each mutation is associated ...
Of all malignant neoplasias affecting women, breast cancer has the highest incidence rate in Brazil....
International audienceThree founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditar...
Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several ...
SummaryBased on breast cancer families with multiple and/or early-onset cases, estimates of the life...
O câncer de mama é um dos mais incidentes no mundo e mais comum na população feminina. Algumas popul...
About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline m...
About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline m...
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and ...
Abstract About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from g...
In Ashkenazi Jewish (AJ) high risk families 3 mutations [2 in BRCA1 (c. 68_69del and c.5266dup) and ...
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma s...
The discovery of BRCA1 and BRCA2 genes has led to the introduction of increasingly sophisticated gen...
Ovarian cancer is a component of the autosomal-dominant hereditary breast-ovarian cancer syndrome an...
Abstract Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ...
carry one of three founding mutations in the BRCA1 and BRCA2 genes, and each mutation is associated ...
Of all malignant neoplasias affecting women, breast cancer has the highest incidence rate in Brazil....
International audienceThree founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditar...